Depurinating Acylfulvene−DNA Adducts: Characterizing Cellular Chemical Reactions of a Selective Antitumor Agent-Reference-Cited by-同舟云学术

Depurinating Acylfulvene−DNA Adducts: Characterizing Cellular Chemical Reactions of a Selective Antitumor Agent

Published:2007-01-27 Issue:7 Volume:129 Page:2101-2111
ISSN:0002-7863
Container-title:Journal of the American Chemical Society
language:en
Short-container-title:J. Am. Chem. Soc.

Author:

Gong Jiachang¹,Vaidyanathan V. G.¹,Yu Xiang¹,Kensler Thomas W.¹,Peterson Lisa A.¹,Sturla Shana J.¹

Affiliation:

1. Contribution from the Department of Medicinal Chemistry, College of Pharmacy, University of Minnesota, Minneapolis, Minnesota 55455, The Cancer Center, University of Minnesota, Minneapolis, Minnesota 55455, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, and School of Public Health, University of Minnesota, Minneapolis, Minnesota 55455

Publisher

American Chemical Society (ACS)

Subject

Colloid and Surface Chemistry,Biochemistry,General Chemistry,Catalysis

Link

https://pubs.acs.org/doi/pdf/10.1021/ja0665951

Reference63 articles.

1. DNA and its associated processes as targets for cancer therapy

2. Chemical approaches to the discovery and development of cancer therapies

3. Mechanisms of in Situ Activation for DNA-Targeting Antitumor Agents

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acylfulvenes covalently interact with thioredoxin as an additional cancer target;Frontiers in Chemical Biology;2024-09-10

2. Click-chemistry-aided quantitation and sequencing of oxidized guanines and apurinic sites uncovers their transcription-linked strand bias in human cells;2024-07-23

3. LP-184, a Novel Acylfulvene Molecule, Exhibits Anticancer Activity against Diverse Solid Tumors with Homologous Recombination Deficiency;Cancer Research Communications;2024-05-06

4. DNA Adducts in Cancer Chemotherapy;Journal of Medicinal Chemistry;2024-03-29

5. Conditional Dependency of LP-184 on Prostaglandin Reductase 1 is Synthetic Lethal in Pancreatic Cancers with DNA Damage Repair Deficiencies;Molecular Cancer Therapeutics;2023-10-02